首页工具

登录

搜索结果

Search Results for "Azido-PEG5-Ala-Ala-Asn-PAB"

Targets Recommended: Others

1

抑制剂 & 化合物

152

化合物库

6

TargetMol 试剂盒

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name
CL0121	ALK inhibitor kit

L6300	药食同源库		1088 compounds
	A unique collection of 1088 compounds from food as medicine for high throughput and high content screening;
L8710	铜死亡化合物库		411 compounds
	TargetMol’s Cuproptosis Compound Library is a collection of 411 compounds related to copper-dependent death that can be used to study its mechanism and related diseases.
L2620	神经退行性疾病化合物库		1622 compounds
	A unique collection of 1622 compounds related to neurodegenerative diseases can be used for HTS or HCS；
L3400	临床期小分子药物库		3142 compounds
	A unique collection of 3142 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);
L9210	儿童药物库		1015 compounds
	A unique collection of 1015 pediatric drugs for high-throughput screening and high-content screening.
L5400	抗心血管疾病化合物库		1428 compounds
	A unique collection of 1428 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS);
L4200	FDA 上市药物库		1729 compounds
	1729个FDA批准药物的独特集合，可用于高通量筛选和高内涵筛选；
L2000	抑制剂库		7618 compounds
	A unique collection of 7618 inhibitors for research in cell signaling, high throughput screening (HTS) and high content screening (HCS) for new drugs;
L3100	造血毒性小分子库		104 compounds
	A unique collection of 104 compounds with defined hematopoietic toxicity for high throughput and high content drug screening;
L4520	抗菌活性库		921 compounds
	A unique collection of 921 antibacterial bioactive compounds, a powerful tool for antibacterial drug development;
L4660	神经疾病库Plus		1246 compounds
	Well-chosen 1246 compounds with unique structures targeting nervous system;
L2192	抗胰腺癌化合物库		2267 compounds
	A unique collection of 2267 pancreatic cancer related compounds can be used in HTS and HCS;
L1600	激酶抑制剂库		2230 compounds
	A unique collection of 2230 kinase inhibitors for high throughput screening and high content screening for drug discovery in kinase related diseases;
L1310	细胞骨架化合物库		590 compounds
	A unique collection of 590 cytoskeleton-related compounds, can be used for HTS and HCS；
L6010	天然产物库		3720 compounds
	A unique collection of 3720 natural products for high throughput screening (HTS) and high content screening (HCS);
L8500	HIF-1化合物库		1352 compounds
	A unique collection of 1352 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies；
L2910	抗氧化化合物库		1040 compounds
	Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. Disturbances in the normal redox state of cells can cause toxic effects through the production of peroxides and free radicals that damage all components of the cell, including proteins, lipids, and DNA. In humans, oxidative stress is thought to be involved in the development of a...
L7300	钾通道分子库		160 compounds
	A unique collection of 160 potassium channel blockers and agonists for high throughput and high content screening;
L6500	微生物天然产物库		254 compounds
	254种微生物来源的生物活性小分子化合物的特有集合，用于高通量、高内涵筛选；
L2521	糖酵解化合物库		560 compounds
	560 glycolysis-related active compounds for high-throughput and high-content screening.
L9820	β-内酰胺类化合物库		105 compounds
	A unique collection of 105 beta-lactam compounds, can be used in HTS and HCS;
L2130	抗癌细胞代谢库		1280 compounds
	A unique collection of 1280 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS);
L6700	抗癌天然产物库		1800 compounds
	A unique collection of 1800 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
L1000	上市药物库		2863 compounds
	A unique collection of 2863 approved drugs for high throughput screening (HTS) and high content screening (HCS);
L2560	代谢化合物库		2350 compounds
	A unique collection of 2350 metabolic pathway-related bioactive small molecule compounds for high-throughput, high-content screening.
L2140	癌细胞分化化合物库		413 compounds
	A unique collection of 413 cancer cell differentiation inducing compounds for high throughput and high content screening;
L2600	神经信号分子库		2011 compounds
	A unique collection of 2011 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs;
L5100	含氟化合物库		583 compounds
	A unique collection of 583 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS);
L8400	血液病分子库		524 compounds
	A unique collection of 524 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS);
L4600	植物来源化合物库		3076 compounds
	A unique collection of 3076 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS);
L3300	组胺&褪黑色素化合物库		155 compounds
	A unique collection of 155 compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS) for new drugs;
L2191	抗乳腺癌化合物库		1965 compounds
	A unique collection of 1965 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study；
L1010	FDA上市及药典收录分子库		3158 compounds
	3158个上市及药典分子集合，可用于高通量筛选和高内涵筛选；
L8000	干细胞分化化合物库		1213 compounds
	A unique collection of 1213 stem cell differentiation signaling targeted compounds for high throughput and high content screening;
L6120	黄酮类天然产物库		477 compounds
	A unique collection of 477 flavonoids can be used for high throughput and high content screening；
L2100	抗癌化合物库		6854 compounds
	A unique collection of 6854 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
L2610	神经递质受体化合物库		1513 compounds
	A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening；
L4020	NO PAINS 化合物库		9555 compounds

L5510	肝脏毒性化合物库		1040 compounds
	A unique collection of 1040 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening；
L4000	经典已知活性库		12862 compounds
	TargetMol created the L4020 NO-PAINS Compound Library that applied the PAINS filter, remaining 12862 small molecules that are suitable for new drug development, signaling pathway research, drug repurposing and other research.
NY1000	天然产物衍生物库		4000 compounds
	The library consists of more than 4,000 members belonging 22 scaffolds (average 180 compounds per scaffold).
L4010	已知活性化合物库		20980 compounds
	A collection of 20980 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification.
L6810	中药单体化合物库		2688 compounds
	A unique collection of 2688 compounds (TCM monomers) sourcing from traditional Chinese Medicines, is a powerful tool for drug discovery and research in mechanism；
L9300	大环化合物库		216 compounds
	216种活性已知的大环化合物，用于高通量、高内涵筛选；
L1300	PI3K/Akt/mTOR 化合物库		425 compounds
	A unique collection of 425 compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling;
L6030	天然产物衍生物虚筛化合物库

DP9200	DGK抑制剂库

L2510	脂代谢化合物库		496 compounds
	A unique collection of 496 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).
L4510	抗寄生虫库		336 compounds
	336 well-chosen unique anti-parasitic small molecules;
L5800	药物代谢杂质库		200 compounds
	A unique collection of 200 drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS);
L6600	胃肠炎天然产物库		223 compounds
	A unique collection of 223 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS);
L6100	天然多酚类化合物库		640 compounds
	A unique collection of 640 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS);
L2195	抗前列腺癌化合物库		2096 compounds
	2096 compounds associated with prostate cancer that can be used for high-throughput and high-content screening.
L5300	线粒体靶向库		447 compounds
	A unique collection of 447 promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine;
L9700	内质网应激化合物库		193 compounds
	A unique collection of 193 endoplasmic reticulum stress (ER stress) related compounds used for high throughput screening (HTS) and high content screening (HCS);
L3200	自噬库		1248 compounds
	A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs;
L9200	药物功能重定位化合物库		4240 compounds
	A unique collection of 4240 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS);
L7400	钠通道分子库		128 compounds
	A unique collection of 128 sodium channel blockers and agonists for high throughput and high content screening;
L6900	稀有天然产物库		284 compounds
	A unique collection of 284 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);
L1720	核苷类化合物库		337 compounds
	A unique collection of 337 nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs;
L6110	生物碱类天然产物库		468 compounds
	A unique collection of 468 natural alkaloids can be used for high throughput and high content screening；
L2540	肠道微生物代谢化合物库		352 compounds
	A unique collection of 352 gut microbial metabolites which can be used for HTS and HCS;
L7700	神经再生化合物库		529 compounds
	A unique collection of 149 neuroregeneration related compounds for high throughput and high content screening;
L4800	血管生成库		1370 compounds
	A unique collection of 1370 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS);
L2900	氧化还原化合物库		1279 compounds
	1279 small molecule compounds with pro-oxidant or anti-oxidant activity for high-throughput and high-content screening.
L1800	抗感染化合物库		2977 compounds
	A unique collection of 2977 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc;
L4700	免疫/炎症分子化合物库		3483 compounds
	A unique collection of 3483 anti-inflammation compounds effective for high throughput screening and high content screening.
L1610	FDA 上市激酶抑制剂库		280 compounds
	Targetmol’s FDA-Approved Kinase Inhibitor Library contains 280 marketed drugs with proven kinase inhibitory activity. These kinases include Insulin/IGF Receptors、PI 3-Kinase、CaM Kinase II、JAK、PKA、CDK、JNK、PKC、CKI II、MAPK、RAF、EGFR、MEK、SAPK、GSK、MLCK、Src-family、IKK、PDGFR、VEGFR etc. FDA-Approved Kinase Inhibitor Library is a powerful tool for kinase drug development and related research.
L9000	细胞凋亡化合物库		1796 compounds
	A unique collection of 1796 apoptosis-related compounds for apoptosis research, research in tumorigenesis, and anti-cancer drug screening;
L9500	表型筛选靶点鉴定库		1832 compounds
	A unique collection of 1832 annotated bioactive compounds with clear targets, suitable for phenotypic screening；
L6730	抗病毒中药单体化合物库		270 compounds
	A collection of 270 TCM monomers with anti-virus activity. An effective tool for drug development and pharmacological studies.
L1110	微管靶向化合物库		80 compounds
	A unique collection of 80 microtubule-targeted compounds can be used in HTS and HCS;
L4500	抗真菌库		253 compounds
	A unique collection of 253 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation.
L8600	泛素化化合物库		214 compounds
	A unique collection of 214 ubiquitination related small chemicals can be used for high throughput and high content screening；
L3800	NF-κB 通路分子库		560 compounds
	A unique collection of 560 compounds targeting NF-κB signaling for high throughput screening and high content screening;
L9860	抗抑郁症化合物库		1181 compounds
	1181 compounds associated with depression that can be used for high-throughput and high-content screening
L2800	5-羟色胺分子库		275 compounds
	A unique collection of 275 compounds targeting serotonin receptors for high throughput screening and high content screening;
L9830	抗帕金森病化合物库		908 compounds
	A unique collection of 908 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS.
L8110	细胞重编程化合物库		1840 compounds
	A unique collection of 1840 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening.
L4300	Wnt/Hedgehog/Notch 通路化合物库		240 compounds
	A unique collection of 240 Wnt/Hedgehog/Notch signaling targeted compounds for high throughput and high content screening;
L6160	Ro5类药天然产物库		2743 compounds
	A unique collection of 2743 natural product monomers that meet the "Lipinski's Rule of Five", a powerful tool for HTS and HCS screening;
L4400	抗生素库		708 compounds
	A unique collection of 708 compounds with antibiotic activity for new antibacterial drug screening;
L3510	甲基化化合物库		131 compounds
	131 methylation-related compounds that can be used for high-throughput and high-content screening.
L9400	PPI抑制剂库		260 compounds
	A unique collection of 260 PPI-related compounds for drug screening;
L2170	肿瘤免疫治疗小分子化合物库		454 compounds
	A unique collection of 454 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening；
L2193	抗肝癌化合物库		1816 compounds
	1816 species of compounds related to liver cancer that can be used in anti-liver cancer drug development and pharmacological studies.
L8720	细胞焦亡化合物库		1077 compounds
	1077 types of active small molecules associated with pyroptosis for high-throughput and high-content screening.
L9600	多肽分子库		533 compounds
	533 peptides can be used in peptide drug development and signaling transduction and mechanism study;
L1510	核受体化合物库		420 compounds
	A unique collection of 420 nuclear receptor signaling targeted compounds for high throughput and high content screening;
L2550	谷氨酰胺代谢化合物库		580 compounds
	A unique collection of 580 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and cancer;
L6710	中药抗炎分子库		1260 compounds
	A collection of 1260 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study；
L6130	萜类天然产物库		349 compounds
	A unique collection of 349 natural terpenes and terpenoids can be used for high throughput and high content screening；
L2194	抗结直肠癌化合物库		1565 compounds
	1565 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening.
L6140	糖类及苷类化合物库		364 compounds
	A unique collection of 364 saccharides and glycosides compounds can be used for HTS and HCS；
L1200	表观遗传库		960 compounds
	Well-chosen 960 compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs;
L1580	GPCR库Plus		338 compounds
	Well-chosen 338 GPCR targeting compounds with unique structures;
L2570	人代谢物化合物库		4532 compounds
	A unique collection of 4532 human metabolites for high-throughput, high-content screening.
L1500	GPCR靶点分子库		1633 compounds
	A unique collection of 1633 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;
L6020	天然产物单体化合物库

L1120	AMPK靶向分子库		64 compounds
	64 well-chosen unique AMPK-targeted small molecules；
L6800	中国药典收录天然产物库		2070 compounds
	A unique collection of 2070 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study;
L7600	趋化因子抑制剂库		59 compounds
	A unique collection of 59 chemokines or chemokine receptors targeted compounds for high throughput and high content screening;
L9420	外泌体相关化合物库		54 compounds
	54 exosome-related compounds that can be used for high-throughput and high-content screening.
L9810	抗纤维化化合物库		1180 compounds
	A unique collection of 1180 potential anti-fibrosis compounds, can be used in HTS and HCS;
L2400	内分泌激素分子库		813 compounds
	A unique collection of 813 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs;
L6620	抗寄生虫天然产物库		233 compounds
	A unique collection of 233 natural products with antiparasitic activity, a powerful tool for high throughput screening (HTS) and high content screening (HCS);
L6200	瑶药化合物库		225 compounds
	A collection of 225 natural product molecules originated from Yao medicine, which can be used for high-throughput and high-content screening.
L7870	可溶性羧酸片段化合物库		1807 compounds

L6150	天然产物共价化合物库		596 compounds
	Detialed biological information and pharmacological information of the products, providing theoretical direction and research basis for screening.
L7850	高溶解性3D结构多样性片段化合物库		1081 compounds
	The library of highly soluble 3D structural diversity fragments contains 1081 compounds.
L6740	抗结直肠癌中药单体化合物库		386 compounds
	A collection of 386 TCM monomers with anti-colorectal activity. An effective tool for drug development and pharmacological studies.
L9410	共价抑制剂库		941 compounds
	A unique collection of 941 covalent Inhibitors and other molecules with common warheads like chloroacetyl，2-Chloropropionyl，Acryloyl，sulfonyl fluoride, alkyne，acrylamide, ketocarbonyl，disulfide bond, etc.
L8300	染色质修饰分子库		256 compounds
	A unique collection of 256 compounds targeting chromatin remodeling pathway for high throughput screening (HTS) and high content screening (HCS);
L4100	TGF-β/Smad靶点化合物库		180 compounds
	A unique collection of 180 TGF-beta/Smad signaling targeted compounds for high throughput and high content screening;
L3700	JAK-STAT 化合物库		256 compounds
	A unique collection of 256 JAK/STAT signaling targeted compounds for high throughput and high content screening;
L6220	蒙药化合物库		960 compounds
	A collection of 960 natural product molecules originated from Mongolian medicine, which can be used for high-throughput and high-content screening.
L6000	高通量筛选天然产物库		4320 compounds
	A unique collection of 4320 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen
L2700	肾上腺素能受体化合物库		219 compounds
	A unique collection of 219 bioactive compounds specifically targeting adrenergic receptors, effective tool for screening new drugs or new target identification;
L6610	抗感染天然产物库		1070 compounds
	A unique collection of 1070 species of natural products with anti-infective activity for high throughput screening (HTS) and high content screening (HCS);
L7200	钙通道分子库		143 compounds
	A unique collection of 143 calcium channel blockers and agonists for high throughput and high content screening;
L2500	人内源代谢化合物库		1400 compounds
	A unique collection of 1400 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening;
L1900	抗糖尿病库		690 compounds
	A unique collection of 690 diabetes related compounds;
L2520	糖代谢化合物库		708 compounds
	708 glycometabolism-related comounds, can be used for HTS and HCT;
L6720	抗COVID-19中药单体库		1162 compounds
	A unique collection of 1162 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening；
L5700	精选片段库		246 compounds
	A unique collection of 246 fragment-like small molecules for FBDD;
L5500	毒性化合物库		277 compounds
	A unique collection of 277 toxic substances for high throughput screening (HTS) and high content screening (HCS);
L1380	转录因子库		704 compounds
	Well-chosen 704 compounds with unique structures targeting transcription factor;
L7100	抗肥胖化合物库		1359 compounds
	A unique collection of 1359 anti-obesity compounds for high throughput and high content screening;
L1700	抗病毒库		800 compounds
	A unique collection of 800 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;
L2200	酪氨酸激酶分子库		746 compounds
	A unique collection of 746 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related diseases;
L3500	组蛋白修饰化合物库		362 compounds
	A unique collection of 362 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS);
L9610	环肽库		58 compounds
	58 species of cyclic peptide molecules for high-throughput and high-content screening;
L6400	海洋天然产物库		94 compounds
	A unique collection of 94 marine natural products for high throughput screening (HTS) and high content screening (HCS);
L1400	MAPK 抑制剂库		367 compounds
	A unique collection of 367 compounds targeting MAPK signaling for drug discovery in MAPK related diseases;
L1710	抗COVID-19化合物库		1160 compounds
	A unique collection of 1160 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents；
L2300	离子通道库		946 compounds
	A unique collection of 946 compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery;
L2160	抗癌活性化合物库		2439 compounds
	A unique collection of 2439 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
L3600	细胞因子抑制剂库		613 compounds
	A unique collection of 613 compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery;
L2150	抗癌药物库		2900 compounds
	A unique collection of 2900 anticancer drugs for high throughput screening (HTS) and high content screening (HCS);
L7000	活性脂质化合物库		385 compounds
	A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsa
L8700	铁死亡化合物库		800 compounds
	A unique collection of 800 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study；
L8100	细胞周期化合物库		695 compounds
	A unique collection of 695 cell cycle related compounds for high throughput screening (HTS) and high content screening (HCS);
L8200	抗衰老化合物库		3324 compounds
	A unique collection of 3324 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS);
L8800	药物片段库		1158 compounds
	1158 drug fragments，a must-have tool for FBDD;
L2110	抗癌上市药物库		1806 compounds
	A unique collection of 1806 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);
L5900	血脑屏障通透化合物库		516 compounds
	A unique collection of 516 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS);
L6210	藏药化合物库		754 compounds
	A collection of 754 natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening.
L2180	抗肿瘤库Plus		1468 compounds
	Well-chosen 1468 anti-tumor compounds with unique structures;
L1100	蛋白酶抑制剂库		344 compounds
	A unique collection of 344 protease and proteasome inhibitors for research in chemical genomics, and drug screening;
L7900	成骨分子库		320 compounds
	A unique collection of 320 osteogenesis related compounds for high throughput and high content screening;
L9840	抗阿尔茨海默症化合物库		1040 compounds
	A unique collection of 1040 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS.

化合物库

ALK inhibitor kit

药食同源库

Compounds: 1088

铜死亡化合物库

神经退行性疾病化合物库

Compounds: 1622

临床期小分子药物库

Compounds: 3142

儿童药物库

Compounds: 1015

抗心血管疾病化合物库

Compounds: 1428

FDA 上市药物库

Compounds: 1729

Compounds: 7618

造血毒性小分子库

抗菌活性库

神经疾病库Plus

Compounds: 1246

抗胰腺癌化合物库

Compounds: 2267

激酶抑制剂库

Compounds: 2230

细胞骨架化合物库

天然产物库

Compounds: 3720

HIF-1化合物库

Compounds: 1352

抗氧化化合物库

Compounds: 1040

钾通道分子库

微生物天然产物库

糖酵解化合物库

β-内酰胺类化合物库

抗癌细胞代谢库

Compounds: 1280

抗癌天然产物库

Compounds: 1800

上市药物库

Compounds: 2863

代谢化合物库

Compounds: 2350

癌细胞分化化合物库

神经信号分子库

Compounds: 2011

含氟化合物库

血液病分子库

植物来源化合物库

Compounds: 3076

组胺&褪黑色素化合物库

抗乳腺癌化合物库

Compounds: 1965

FDA上市及药典收录分子库

Compounds: 3158

干细胞分化化合物库

Compounds: 1213

黄酮类天然产物库

抗癌化合物库

Compounds: 6854

神经递质受体化合物库

Compounds: 1513

NO PAINS 化合物库

Compounds: 9555

肝脏毒性化合物库

Compounds: 1040

经典已知活性库

Compounds: 12862

天然产物衍生物库

Compounds: 4000

已知活性化合物库

Compounds: 20980

中药单体化合物库

Compounds: 2688

大环化合物库

PI3K/Akt/mTOR 化合物库

天然产物衍生物虚筛化合物库

DGK抑制剂库

脂代谢化合物库

抗寄生虫库

药物代谢杂质库

胃肠炎天然产物库

天然多酚类化合物库

抗前列腺癌化合物库

Compounds: 2096

线粒体靶向库

内质网应激化合物库

Compounds: 1248

药物功能重定位化合物库

Compounds: 4240

钠通道分子库

稀有天然产物库

核苷类化合物库

生物碱类天然产物库

肠道微生物代谢化合物库

神经再生化合物库

血管生成库

Compounds: 1370

氧化还原化合物库

Compounds: 1279

抗感染化合物库

Compounds: 2977

免疫/炎症分子化合物库

Compounds: 3483

FDA 上市激酶抑制剂库

细胞凋亡化合物库

Compounds: 1796

表型筛选靶点鉴定库

Compounds: 1832

抗病毒中药单体化合物库

微管靶向化合物库

泛素化化合物库

NF-κB 通路分子库

抗抑郁症化合物库

Compounds: 1181

5-羟色胺分子库

抗帕金森病化合物库

细胞重编程化合物库

Compounds: 1840

Wnt/Hedgehog/Notch 通路化合物库

Ro5类药天然产物库

Compounds: 2743

甲基化化合物库

PPI抑制剂库

肿瘤免疫治疗小分子化合物库

抗肝癌化合物库

Compounds: 1816

细胞焦亡化合物库

Compounds: 1077

多肽分子库

核受体化合物库

谷氨酰胺代谢化合物库

中药抗炎分子库

Compounds: 1260

萜类天然产物库

抗结直肠癌化合物库

Compounds: 1565

糖类及苷类化合物库

表观遗传库

人代谢物化合物库

Compounds: 4532

GPCR靶点分子库

Compounds: 1633

天然产物单体化合物库

AMPK靶向分子库

中国药典收录天然产物库

Compounds: 2070

趋化因子抑制剂库

外泌体相关化合物库

抗纤维化化合物库

Compounds: 1180

内分泌激素分子库

抗寄生虫天然产物库

瑶药化合物库

可溶性羧酸片段化合物库

Compounds: 1807

天然产物共价化合物库

高溶解性3D结构多样性片段化合物库

Compounds: 1081

抗结直肠癌中药单体化合物库

共价抑制剂库

染色质修饰分子库

TGF-β/Smad靶点化合物库

JAK-STAT 化合物库

蒙药化合物库

高通量筛选天然产物库

Compounds: 4320

肾上腺素能受体化合物库

抗感染天然产物库

Compounds: 1070

钙通道分子库

人内源代谢化合物库

Compounds: 1400

抗糖尿病库

糖代谢化合物库

抗COVID-19中药单体库

Compounds: 1162

精选片段库

毒性化合物库

转录因子库

抗肥胖化合物库

Compounds: 1359

酪氨酸激酶分子库

组蛋白修饰化合物库

海洋天然产物库

MAPK 抑制剂库

抗COVID-19化合物库

Compounds: 1160

离子通道库

抗癌活性化合物库

Compounds: 2439

细胞因子抑制剂库

抗癌药物库

Compounds: 2900

活性脂质化合物库

铁死亡化合物库

细胞周期化合物库

抗衰老化合物库

Compounds: 3324

药物片段库

Compounds: 1158

抗癌上市药物库

Compounds: 1806

血脑屏障通透化合物库

藏药化合物库

抗肿瘤库Plus

Compounds: 1468

蛋白酶抑制剂库

成骨分子库

抗阿尔茨海默症化合物库

Compounds: 1040

Cat. No.	Product Name	Form	Specificity Of Inhibition
C0045	RIPA Lysis Buffer (Strong) RIPA Lysis Buffer (Strong)
C0004	Phosphatase Inhibitor Cocktail III (2 Tubes, 100x) 磷酸酶抑制剂 Cocktail III	2 Tube Solution (100×)	Each Tube has different specificity of inhibition
C0003	Phosphatase Inhibitor Cocktail II (100× DMSO) 磷酸酶抑制剂 Cocktail II	Solution (100× in DMSO)	Alkaline phosphatases, Ser/Thr phosphatases, Acid and PP1 and PP2A
C0002	Phosphatase Inhibitor Cocktail I (100× ddH2O) 磷酸酶抑制剂 Cocktail I	Solution (100× in ddH2O)	Acid Phosphatase, Alkaline phosphatase, PTPs, ATPases
C0001	Protease Inhibitor Cocktail 蛋白酶抑制剂 Cocktail	Solution (EDTA-Free,100× in DMSO)	Serine proteases, Aminopeptidases, Cysteine proteases, Aspartic proteases
C0005	Cell Counting Kit-8 (CCK-8) Cell Counting Kit-8 (CCK-8)	Solution in bottle

TargetMol 试剂盒

RIPA Lysis Buffer (Strong)

磷酸酶抑制剂 Cocktail III

磷酸酶抑制剂 Cocktail II

磷酸酶抑制剂 Cocktail I

蛋白酶抑制剂 Cocktail

Cell Counting Kit-8 (CCK-8)

Cat. No.	Product Name	Target	Signaling Pathways
T14455	Azido-PEG5-Ala-Ala-Asn-PAB	Others	Others
	Azido-PEG5-Ala-Ala-Asn-PAB is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1].

化合物

Azido-PEG5-Ala-Ala-Asn-PAB

我们的所有产品和服务仅用于科学研究，不能被用于人体，我们也不向个人提供产品和服务。

Copyright © 2015-2022 TargetMol Chemicals Inc. All rights reserved. 沪ICP备20019793号-4

沪公网安备 31010602006700号